ASS1 and non-small cell lung carcinoma: revealed that ASS1 was expressed mainly by cancer cells of non-small-cell lung cancer (NSCLC) (75/98 cases; 76.5%) and patients with ASS1 expression by cancer cells had a better prognosis (31).